Aethlon Medical, Inc.
AEMD
$0.4376
-$0.0124-2.76%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | 4,283.21% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | 4,283.21% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | 4,283.21% |
| SG&A Expenses | -20.24% | -14.19% | -15.32% | -5.60% | -6.73% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -20.24% | -14.19% | -15.32% | -5.60% | -6.73% |
| Operating Income | 16.34% | 10.05% | 11.40% | 1.05% | 10.99% |
| Income Before Tax | 21.97% | 3.12% | 7.33% | -1.48% | 8.24% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 21.97% | 3.12% | 7.33% | -1.48% | 8.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 21.97% | 3.12% | 7.33% | -1.48% | 8.23% |
| EBIT | 16.34% | 10.05% | 11.40% | 1.05% | 10.99% |
| EBITDA | 16.75% | 10.43% | 12.13% | 2.08% | 12.42% |
| EPS Basic | 68.20% | 41.72% | 29.68% | 19.15% | 32.20% |
| Normalized Basic EPS | 65.75% | 48.73% | 35.10% | 23.97% | 36.29% |
| EPS Diluted | 68.20% | 41.72% | 29.68% | 19.15% | 32.20% |
| Normalized Diluted EPS | 65.75% | 48.73% | 35.10% | 23.97% | 36.29% |
| Average Basic Shares Outstanding | 290.55% | 179.21% | 65.81% | 22.42% | 30.39% |
| Average Diluted Shares Outstanding | 290.55% | 179.21% | 65.81% | 22.42% | 30.39% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
